Non-steroidal anti-inflammatory drugs in prevention of gastric cancer.
about
COX-2 Inhibitors and Gastric CancerEtiology and Prevention of Gastric CancerUltrastructural observations on inflammatory angiogenesis in gastric carcinomas with massive neutrophil infiltration.PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3).Fruit and vegetable consumption and risk of distal gastric cancer in the Shanghai Women's and Men's Health studies.The association of Streptococcus bovis/gallolyticus with colorectal tumors: the nature and the underlying mechanisms of its etiological role.Anti-Helicobacter pylori therapy followed by celecoxib on progression of gastric precancerous lesionsNonsteroidal antiinflammatory drugs and risk of gastric adenocarcinoma: the multiethnic cohort studyThe risk of gastric cancer in patients with duodenal and gastric ulcer: research progresses and clinical implications.Prevention of posterior capsular opacification through cyclooxygenase-2 inhibition.The proapoptotic effect of traditional and novel nonsteroidal anti-inflammatory drugs in mammalian and yeast cells.Potency of non-steroidal anti-inflammatory drugs in chemotherapy.Hit identification and biological evaluation of anticancer pyrazolopyrimidines endowed with anti-inflammatory activity.Susceptibility for NSAIDs-induced apoptosis correlates to p53 gene status in gastric cancer cells.Bile acid induces expression of COX-2 through the homeodomain transcription factor CDX1 and orphan nuclear receptor SHP in human gastric cancer cells.Characterization of the effects of cyclooxygenase-2 inhibition in the regulation of apoptosis in human small and non-small cell lung cancer cell lines.Cyclooxygenase-2 overexpression in chronic inflammation associated with benign prostatic hyperplasia: is it related to apoptosis and angiogenesis of prostate cancer?Late administration of a specific COX-2 inhibitor does not treat and/or prevent progression of gastric tumors in rats submitted to duodenogastric reflux procedure.
P2860
Q27692701-F1EF3BE7-3A6B-473C-8DD7-3FEB67B0897BQ28072819-E3E646BD-17A0-4190-9491-C548678B90CCQ33405298-4936BB17-23A8-4E8D-883F-35757A4861B2Q33705238-11B38BB2-CBC2-4C9F-A2EA-EE73E934F59DQ34179440-0E2D7A18-B8BE-43DA-B4BC-C726BF68CB1DQ34547396-365E880F-177A-45EC-8667-9C264EDBB57CQ37226245-A77ACE06-5DB3-4ACF-AC9B-F25B508AE22EQ37305861-EB0E999E-D639-4DE6-A141-9006F5204F2AQ37344332-1F0C6FAA-A3E1-4D6A-9C4B-2C8AA3ECC29FQ37395621-6B08F724-F9E5-4EB5-99A7-724B1E7E4E31Q38132159-8108E653-78AE-4C23-B029-7ED528E4E713Q38282100-D142EB45-99D3-4E79-B85E-BD30D08522EEQ39690297-C6FE3A53-890C-4C6F-8CC6-A00AE20B74FBQ39938961-BDBBB9D4-83CF-4B32-83F3-D3D6C03EF5F4Q39942512-BA37E739-E50B-483B-92EA-C9D321C4E4ACQ40113431-05F1AB22-4B20-435A-9CC4-3B1B30A23495Q42725155-36F1B330-AEC9-42C7-9514-143842933D77Q48229709-AF751D05-114F-4D6B-BEB0-5E0C6F6EB5D2
P2860
Non-steroidal anti-inflammatory drugs in prevention of gastric cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Non-steroidal anti-inflammatory drugs in prevention of gastric cancer.
@ast
Non-steroidal anti-inflammatory drugs in prevention of gastric cancer.
@en
type
label
Non-steroidal anti-inflammatory drugs in prevention of gastric cancer.
@ast
Non-steroidal anti-inflammatory drugs in prevention of gastric cancer.
@en
prefLabel
Non-steroidal anti-inflammatory drugs in prevention of gastric cancer.
@ast
Non-steroidal anti-inflammatory drugs in prevention of gastric cancer.
@en
P2860
P356
P1476
Non-steroidal anti-inflammatory drugs in prevention of gastric cancer.
@en
P2093
Wei-Hong Wang
P2860
P304
P356
10.3748/WJG.V12.I18.2884
P407
P577
2006-05-01T00:00:00Z